Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
52.4M
-
Number of holders
-
105
-
Total 13F shares, excl. options
-
17.2M
-
Shares change
-
+17.2M
-
Total reported value, excl. options
-
$441M
-
Value change
-
+$441M
-
Put/Call ratio
-
0.36
-
Number of buys
-
102
-
Price
-
$25.63
Significant Holders of 2seventy bio, Inc. - Common Stock (TSVT) as of Q4 2021
108 filings reported holding TSVT - 2seventy bio, Inc. - Common Stock as of Q4 2021.
2seventy bio, Inc. - Common Stock (TSVT) has 105 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 17.2M shares
of 52.4M outstanding shares and own 32.8% of the company stock.
Largest 10 shareholders include STATE STREET CORP (2.36M shares), WELLINGTON MANAGEMENT GROUP LLP (2.09M shares), EcoR1 Capital, LLC (1.92M shares), VANGUARD GROUP INC (1.86M shares), BlackRock Inc. (1.6M shares), ARMISTICE CAPITAL, LLC (856K shares), BAKER BROS. ADVISORS LP (833K shares), Point72 Asset Management, L.P. (587K shares), GOLDMAN SACHS GROUP INC (508K shares), and Newtyn Management, LLC (465K shares).
This table shows the top 105 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.